Royalty Pharma PLC at Bank of America Merrill Lynch Global Healthcare Conference Transcript
We have Royalty Pharma with us. And speaking on behalf of Royalty is CFO, Terry Coyne. Coyne, welcome.
Hi, Geoff, thanks for having us.
And so what we're going to do today is Terry is just going to give a quick background for those in the room and on the webcast, and then we'll do some Q&A.
Great. Well, first of all, thanks, Geoff, and BoA for having us at this conference. Really enjoying it. So -- Okay, here we go. So this -- here are our forward-looking statements. Royalty Pharma is a fairly new public company. We went public in June of 2020, but we've actually been doing this for a very long time. The company was founded in 1996. We have -- actually, this is a little outdated. We
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
